World Health Organisation (WHO) experts on Friday issued recommendations that the interval between administration of two doses of the Pfizer-BioNTech
WHO's Strategic Advisory Group of Experts on
But the UN health agency also noted that “a number of countries face exceptional circumstances of vaccine supply constraints combined with a high disease burden,” and said some have been considering delaying the administration of a second dose as a way to broaden initial coverage.
Tedros Disappointed as China Blocks Entry Of WHO Expert Team To track Coronavirus Origin
WHO's big statement 'UK variant of corona strain detected in 41 countries'